19 Dec 2014 – Drug-resistant superbugs could cost up to $100 trillion and cause 10 million extra deaths a year by 2050

In a report published on the 11th December by the Review on Antimicrobial Resistance, set up by the UK Prime Minister David Cameron, it has been estimated that drug-resistant infections will cost the world 10 million extra deaths a year and up to $100 trillion by 2050, if the global increase is not stopped. Drug-resistant infections already kill hundreds of thousands of people globally every year, and the trend is growing. The analysis was produced by RAND and KPMG, with input from experts in the scientific community. Jim O’Neill, Chairman of the Review on AMR, said: “Drug-resistant infections already kill hundreds of thousands a year globally, and by 2050 that figure could be more than 10 million. The economic cost will also be significant, with the world economy being hit by up to $100 trillion by 2050 if we do not take action.” Dr Bill Love, CEO of Destiny Pharma said “The figures in this report, particularly the potential human cost of not addressing antibiotic resistance are quite frightening. Fortunately the report does make the case that this crisis can be averted if global action is taken soon to address this huge problem the report highlights just how great the need for new antimicrobial drugs is.”

Leave a Reply

Your email address will not be published. Required fields are marked *